BiVACOR

A Total Artificial Heart (TAH), to replace complete function of a patient’s failing heart

Visit Website
north_east
  • Sector

    Healthcare & biotech

  • lead partner

    Dr Paul Kelly

  • Deal Team

    Dr Michelle Deaker, Anne-Marie Birkill

  • 1V Board Representation

    Dr Paul Kelly, Chairman(2011-current),
    Sarah Meibusch, Alternate Director (Board Observer)
    (2020 – current), Anne-Marie Birkill,
    Board Observer (2016-2020),
    Dr Michelle Deaker, Board Observer (2011-2014)

Synopsis

Participated in Series A financing to fund the development of the external controller for the TAH (February 2018)

chevron_leftPreviosly
Prota Therapeutics
18 May 2022
Nextchevron_right
8i
18 May 2022
decor decor decor
decor decor decor decor decor
clear Close